Pathogenic differences in phosphorylation of S268 and S270 would be expected to result in similar phenotypes to a genetic phospho-null model, and indeed the kinases that target these sites (ERK1/2 and GSK3β) show altered signaling in models of psychiatric disorders [24, 28, 83, 84]. The gene discussed is MAPK3; the disease is psychiatric disorder.